跳至主要内容
临床试验/NCT05817266
NCT05817266撤回不适用

Role of Field-Cycling Imaging in the Detection of Proctosigmoiditis Caused by Inflammatory Bowel Disease

NHS Grampian2 个研究点 分布在 1 个国家开始时间: 2024年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
NHS Grampian
试验地点
2
主要终点
Detection of proctosigmoiditis assessed by field-cycling imaging (FCI) scan

研究概览

简要总结

The goal of this pilot study is to explore the ability of field-cycling imaging, a new scanning technology being developed at the University of Aberdeen, to detect active disease in patients with proctosigmoiditis caused by inflammatory bowel disease.

详细描述

Field-cycling imaging (FCI) is an emerging technology that is being developed at the University of Aberdeen. It combines the use of a moderately high magnetic field (200mT) with the ability to probe low magnetic fields (0.2mT) so that image resolution can be preserved while also exploiting the high contrast present at low magnetic fields. This non-invasively provides quantitative data on the molecular dynamics in the tissues.

FCI represents a potentially new, non-invasive, way of assessing the extent and activity of inflammatory bowel disease (IBD). IBD can affect the rectum and distal sigmoid colon, this condition is called Proctosigmoiditis (PS). Currently, diagnosis of IBD depends on endoscopy for direct visualisation of the upper and lower gut, using CT scanning, with its attendant use of ionising radiation, and conventional MRI, particularly for the small bowel. Determining the activity of IBD remains a continuing challenge.

In this proof-of-concept study, the investigators will explore the ability of FCI to detect active disease in patients with PS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants with a diagnosis of proctosigmoiditis, on the basis of a compatible history and previous flexible sigmoidoscopy
  • Participants who are already under follow up in the NHS Grampian IBD clinic
  • Participants must be between 16 and 80 years old
  • Participants who meet the safety criteria for undergoing an MRI scan
  • Participants who are able to fit inside the scanner
  • Participants must be able to give fully informed consent
  • Participants must be mobile enough to be positioned onto the FCI scanner couch

排除标准

  • MRI-incompatible conditions, as detected in the MRI safety screening sheet
  • Participants under 16 years old
  • Participants who are unable to communicate in English
  • Participants who are unable to give fully informed consent
  • Women who are pregnant
  • Restrictions to mobility that would prevent the correct positioning in the scanner
  • Previous major abdominal surgery
  • Any known significant comorbid disease that might interfere with treatment
  • Malignancy or other conditions that would significantly reduce life expectancy
  • Participants who suffer from claustrophobia

结局指标

主要结局

Detection of proctosigmoiditis assessed by field-cycling imaging (FCI) scan

时间窗: At baseline

Validation of FCI T1 dispersion profiles as non-invasive technology able to detect proctosigmoiditis in participants with inflammatory bowel disease (IBD).

次要结局

  • Extent of proctosigmoiditis measured by field-cycling imaging (FCI) scan(At baseline)

研究者

发起方
NHS Grampian
申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验